EUVIMEDEUVIMED entdecken
Crossref

Targeting the URG4 Signaling Axis with Valproic Acid: Implications for Chordoma Therapy

Kevser Eryıldız, Çağla Nur Tüten, Ömer Mete Başkan, Furkan Ayaz, Esra Aydemir

Journal of Neurological Surgery Part B: Skull Base · 30.10.2026

DOI: 10.1055/a-2988-5874 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, online erschienen am 30.10.2026. Verfasst von Kevser Eryıldız und 4 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chordoma is a rare malignant tumor originating from notochordal remains, characterized by its aggressiveness and elevated recurrence rates. The limited efficacy of traditional therapies necessitates the exploration of new epigenetic targets. Valproic acid (VPA), a histone deacetylase inhibitor, had antiproliferative effects by restoring the expression of tumor suppressor genes. Upregulated gene 4 (URG4), an oncogene involved in cell proliferation and tumor growth, has been discovered as a possible therapeutic target. However, its role in chordoma remains unexplored. This study examined the effects of VPA on the chordoma cell line using multiple assays. Cell viability was evaluated via MTT assay, while cell migration was assessed using the wound healing assay. Clonogenic capacity was analyzed by colony formation assay. The effect of VPA on URG4 gene expression was measured by RT-qPCR. Treatment with 750 µM VPA resulted in a time-dependent reduction in cell viability and migration. The number of colonies was markedly decreased compared with the control group. RT-qPCR analysis revealed that URG4 gene expression was downregulated approximately 4-fold in VPA-treated cells. VPA demonstrated antiproliferative and antimigratory effects on chordoma cells. These findings suggest that VPA may represent a promising epigenetic agent for targeted therapy in chordoma.

Zitieren

APA

Eryıldız, K., Tüten, Ç. N., Başkan, Ö. M., Ayaz, F., & Aydemir, E. (2026). Targeting the URG4 Signaling Axis with Valproic Acid: Implications for Chordoma Therapy. Journal of Neurological Surgery Part B: Skull Base. https://doi.org/10.1055/a-2988-5874

Vancouver

Eryıldız K, Tüten ÇN, Başkan ÖM, Ayaz F, Aydemir E. Targeting the URG4 Signaling Axis with Valproic Acid: Implications for Chordoma Therapy. Journal of Neurological Surgery Part B: Skull Base. 2026. doi:10.1055/a-2988-5874

BibTeX
@article{Eryldz2026,
  author = {Eryıldız, Kevser and Tüten, Çağla Nur and Başkan, Ömer Mete and Ayaz, Furkan and Aydemir, Esra},
  title = {Targeting the URG4 Signaling Axis with Valproic Acid: Implications for Chordoma Therapy},
  journal = {Journal of Neurological Surgery Part B: Skull Base},
  year = {2026},
  doi = {10.1055/a-2988-5874}
}
Kostenlos starten →